BeiGene | A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

⟵ Back to Search Results

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

Beigene Study ID

BG-68501-101

ClinicalTrials.gov ID

NCT06257264

Sex: All

Age: 18 Years / N/A

No Study Documents

Locations

Sex: All

Age: 18 Years / N/A

No Study Documents